HDR Gateway logo
HDR Gateway logo

Bookmarks

Hypertonic saline nasal irrigation and gargling for suspected COVID-19

Population Size

Not reported

Years

2021 - 2021

Associated BioSamples

None/not available

Geographic coverage

Pakistan

Lead time

Other

Summary

Pragmatic web-based Bayesian adaptive randomised controlled trial using hypertonic saline. This data was collected in a study that tries to find out if nasal washing and gargling with salt-water helps individuals get better faster.

Documentation

COVID-19 and the ‘common cold’ are both caused by viruses that get into the respiratory tract. Some studies with patients with the common cold have found that nasal washing and gargling with salt-water may be helpful in reducing the length of the illness . However, we do not know if this same benefit is also seen in patients with suspected or confirmed COVID-19. This study will help us find out if nasal washing and gargling with salt-water are helpful in COVID-19. The study involved randomly selected individuals who fulfil the criteria of having the following symptoms: (i) Respiratory symptoms, such as cough and shortness of breath, (ii) Fever, (iii) Muscle pain, (iv) Headache, (v) Sore throat, (vi) New loss of taste or smell, (vii) Severe fatigue.

Individuals who have one or more symptoms of SARS-CoV2 are encouraged to signup for the study on a website. They fill a few forms are then divided randomly into a control and treatment group. Control group participants are advised to follow the standard treatment suggested by Government of Pakistan. The treatment group also follows the standard recommendations but along it perform saline nasal wash a few times a day. The participants of both groups fill a form everyday to record their symptoms for 14 days and then an end of study form. The data shared records the responses of the participants that were collected digitally.

Dataset type
Health and disease
Dataset sub-type
Not applicable

Keywords

SALINE, NASAL, WASHING, GARGLING, treatment, Recovery, COVID-19, SARS-CoV2

Observations

Observed Node
Disambiguating Description
Measured Value
Measured Property
Observation Date

Findings

Observations detail not provided for inclusion here and default values used in mandatory fields

1

Count

30 Nov 2021

Provenance

Purpose of dataset collection
Study
Collection source setting
Other
Image contrast
Not stated
Biological sample availability
None/not available

Details

Publishing frequency
Static
Version
1.0.0
Modified

08/10/2024

Citation Requirements
RESPIRE

Coverage

Start date

01/05/2021

End date

30/11/2021

Time lag
Not applicable
Geographic coverage
Pakistan
Minimum age range
18
Maximum age range
65

Accessibility

Language
en
Controlled vocabulary
LOCAL
Format
CSV

Data Access Request

Dataset pipeline status
Not available
Time to dataset access
Other
Access method category
Varies based on project
Access service description
Access is managed on a project-by-project basis. Contact the RESPIRE Collaboration.
Jurisdiction
PK, GB-ENG, GB-SCT
Data Controller
RESPIRE Collaboration
Data Processor
RESPIRE Collaboration

Dataset Types: Health and disease


Collection Sources: Other